ClinicalTrials.Veeva

Find clinical trials for Lymphoma in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Tampa, FL, USA:

A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

The purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma...

Enrolling
Central Nervous System Lymphoma
Drug: Acalabrutinib
Drug: Isavuconazole

Phase 2

UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center

Tampa, Florida, United States and 2 other locations

This is a Phase 1/2 study of imvotamab in adult subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma. This study will consist of...

Active, not recruiting
Marginal Zone Lymphoma
Mantle Cell Lymphoma
Drug: imvotamab

Phase 1, Phase 2

IGM Biosciences

Tampa, Florida, United States and 26 other locations

Locations recently updated

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Enrolling
Lymphoma, Non-Hodgkin
Drug: CC-99282
Drug: Tafasitamab

Phase 1, Phase 2

Celgene
Celgene

Tampa, Florida, United States and 88 other locations

A Phase 1/2 Study of bbT369, a dual targeting CAR T cell drug product with a gene edit, in Relapsed and/or Refractory B cell Non-Hodgkin's Lymphoma...

Enrolling
Diffuse Large B Cell Lymphoma (DLBCL)
Biological: bbT369

Phase 1, Phase 2

2seventy bio

Tampa, Florida, United States and 3 other locations

purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...

Active, not recruiting
Lymphoma
Drug: Parsaclisib

Phase 2

Incyte
Incyte

Spring Hill, Florida, United States and 82 other locations

of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...

Active, not recruiting
Relapsed/Refractory Follicular Lymphoma
Relapsed/Refractory Large B Cell Lymphoma
Drug: Fludarabine
Drug: Cyclophosphamide

Phase 1

Allogene Therapeutics

Tampa, Florida, United States and 6 other locations

in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton...

Active, not recruiting
Lymphoma
Drug: Parsaclisib

Phase 2

Incyte
Incyte

Weeki Wachee, Florida, United States and 85 other locations

This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.

Active, not recruiting
Follicular Lymphoma
Biological: tisagenlecleucel

Phase 2

Novartis
Novartis

Tampa, Florida, United States and 29 other locations

with various types of blood cancers:relapsed or refractory (R/R) lymphomamultiple myelomanewly diagnosed acute myeloid leukemia (AML).This t...

Active, not recruiting
Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Dexamethasone
Drug: Venetoclax

Phase 1

Pfizer
Pfizer

Tampa, Florida, United States and 61 other locations

of this study is to characterize the safety and efficacy profile of ACP-196 (acalabrutinib) in subjects with relapsed or refractory Mantle Cell Lymphoma...

Active, not recruiting
Mantle Cell Lymphoma (MCL)
Drug: ACP-196 (acalabrutinib)

Phase 2

Acerta Pharma
Acerta Pharma

Tampa, Florida, United States and 57 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems